Oslo, Norway – Crown Princess Mette-Marit of Norway, 52, is being evaluated for a lung transplant following a deterioration in her health, the Royal Household announced. The Princess was diagnosed with pulmonary fibrosis in 2018, a degenerative condition that causes scar tissue to form in the lungs, impeding breathing and oxygen absorption.
Medical assessments conducted in autumn indicated a significant decline in her condition. Dr. Are Martin Holm, head of respiratory medicine at Oslo University Hospital, stated that a lung transplant is becoming necessary. Princess Mette-Marit confirmed to public broadcaster NRK that her illness has progressed more rapidly than anticipated.
Transplant Evaluation Process
While no definitive decision has been made regarding her placement on a transplant waiting list, her medical team has initiated the evaluation process for lung transplant surgery. In Norway, lung transplant waiting lists typically comprise 20 to 40 patients, and local media reports confirm that Princess Mette-Marit will not receive preferential treatment. Dr. Holm noted that necessary preparations are underway to facilitate a transplant when required.
Impact on Health and Duties
The Royal Household indicated that Princess Mette-Marit requires increased rest and a specific exercise regimen. Despite these health challenges, she has expressed a strong commitment to continuing her royal duties, which will be adjusted to accommodate her ongoing medical needs.
Dr. Holm described pulmonary fibrosis as a serious disease where symptoms, particularly breathing difficulties, may not be apparent at rest but become evident during physical exertion. Crown Prince Haakon, her husband, observed that she exhibits less energy and experiences more frequent illnesses. Activities such as hiking and skiing, which the couple previously enjoyed, are no longer feasible for the Princess.
Princess Mette-Marit acknowledged the risks associated with a transplant and the demanding nature of the procedure. Dr. Holm explained that lung transplants are considered a last resort for individuals with significant illness and a limited life expectancy.